Womens Fashion By Joanne Louise

We have always stated that companies that structure their sales around cheap clothing have never considered the impact to fellow humans regardless from which country the reside.

How can it be ethical to have the lowest retail prices available to consumers and then state that they are a fair trade company?

Primark have recently been given bad publicity with the apparent use of child labour on their products.. but were the manufacturers forced into this through a price driven ethos? or just greed.. Who knows but companies who promote themselves on price surely must be made accountable.

We all have our own thoughts but the consumer has to realise that although price is important they do have a choice. And that choice given that the retail industry is very competitive will ultimately have an impact on another individual.

It would be deemed as illegal to produce products in this country with the use of child labour, let alone the conditions which they are being produced.

A Transgender man has claimed to be pregnant with a baby girl, according to news reports.

Thomas Beatie, who was born a woman, has reportedly said the experience so far had been “incredible” and that he is lucky to have such a supportive wife.

Living in Oregon the news was written for a US website, said that he decided to keep his female reproductive organs when he became transgender but he had a breast reduction and underwent testosterone therapy. His wife, Nancy had a hysterectomy due to severe endometriosis, so the couple began to think about Mr Beatie carrying a child.

This meant Mr Beatie had to stop taking his testosterone injections but claims that his body regulated itself after just a few months.

He said: “I stopped taking my bimonthly testosterone injections. It had been roughly eight years since I had my last menstrual cycle, so this wasn’t a decision that I took lightly.

“My body regulated itself after about four months, and I didn’t have to take any exogenous estrogen, progesterone, or fertility drugs to aid his pregnancy.”

But a tv station that has been investigating the story has questioned the validity of Mr Beatie’s claims.

‘Discrimination’

Mr Beatie’s neighbour Ron Schlieper said: “Quite frankly, I think it’s a hoax.

“I saw him a few days ago and he didn’t look like that.”

Mr Beatie claims this is his second pregnancy - the first was apparently an ectopic pregnancy with triplets.

“It was a life-threatening event that required surgical intervention, resulting in the loss of all embryos and my right fallopian tube,” he said.

“When my brother found out about my loss, he said, ‘It’s a good thing that happened. Who knows what kind of monster it would have been’.”

Mr Beatie said he and his wife had felt discriminated against because of the pregnancy.

“Doctors have discriminated against us, turning us away due to their religious beliefs,” he said.

“Health care professionals have refused to call me by a male pronoun or recognise Nancy as my wife.

If you resprayed a car blue when it was originally red would you call it a red car or blue one? but then again if it was originally a 2 ltr, 3 series Bmw for example is it wrong to call it a 3 series bmw.

With this in mind the news title should have said ” girl turned man is now pregnant,” which really isn’t national news…

Is the world really that quiet for this to make first page news?

WWW.J-LOU.COM

Anti Depressants A Waste Of Time

 
 
New research has shown that new generation anti-depressants work no better that placebo dummy pills seized upon evidence that doctors are over prescribing.

 
Campaigners from the Mental Health said that millions of people with depression are not getting sufficient access to talking to therapists due to GP’s being over reliant on prescribing drugs such as Prozac.  

 
It follows a review of clinical trials that found that such drugs had no more effect than a placebo for mildly depressed patients and for most people suffering severe depression.
The study showed that even trials suggesting benefits for severely depressed people did not provide evidence of clear clinical benefit, researchers said.
Dr Tim Kendall, deputy director of the Royal College of Psychiatrists Research Unit, said the findings were “fantastically important”.
A group of experts, led by Professor Irving Kirsch, from the Department of Psychology at the University of Hull, analysed 47 clinical trials using data released under Freedom of Information rules by the US Food and Drug Administration.
The researchers looked at four commonly used anti-depressants and the clinical trials submitted to gain licensing approval. They included anti-depressants regularly prescribed in the UK, including fluoxetine (Prozac), venlafaxine (Efexor) and paroxetine (Seroxat).
They found little evidence of benefit when analysing both unpublished and published data from the drug companies. Furthermore, the seemingly good results for very severely depressed patients came from the fact a patient’s response to the dummy pill decreased rather than any notable increase in their response to antidepressants.
Professor Kirsch said: “The difference in improvement between patients taking placebos and patients taking antidepressants is not very great. This means that depressed people can improve without chemical treatments.”
Alison Cobb, policy officer at mental health charity Mind, said: “This research is a serious challenge to the predominance of drugs in treating depression. Nine out of 10 GPs say they’ve been forced to dish out drugs because they don’t have proper access to talking treatments such as cognitive behavioural therapy, which are recommended as the first-line treatment for mild to moderate depression.”
Anti Depressants A Waste Of Time

 
 
New research has shown that new generation anti-depressants work no better that placebo dummy pills seized upon evidence that doctors are over prescribing.

 
Campaigners from the Mental Health said that millions of people with depression are not getting sufficient access to talking to therapists due to GP’s being over reliant on prescribing drugs such as Prozac.  

 
It follows a review of clinical trials that found that such drugs had no more effect than a placebo for mildly depressed patients and for most people suffering severe depression.
The study showed that even trials suggesting benefits for severely depressed people did not provide evidence of clear clinical benefit, researchers said.
Dr Tim Kendall, deputy director of the Royal College of Psychiatrists Research Unit, said the findings were “fantastically important”.
A group of experts, led by Professor Irving Kirsch, from the Department of Psychology at the University of Hull, analysed 47 clinical trials using data released under Freedom of Information rules by the US Food and Drug Administration.
The researchers looked at four commonly used anti-depressants and the clinical trials submitted to gain licensing approval. They included anti-depressants regularly prescribed in the UK, including fluoxetine (Prozac), venlafaxine (Efexor) and paroxetine (Seroxat).
They found little evidence of benefit when analysing both unpublished and published data from the drug companies. Furthermore, the seemingly good results for very severely depressed patients came from the fact a patient’s response to the dummy pill decreased rather than any notable increase in their response to antidepressants.
Professor Kirsch said: “The difference in improvement between patients taking placebos and patients taking antidepressants is not very great. This means that depressed people can improve without chemical treatments.”
Alison Cobb, policy officer at mental health charity Mind, said: “This research is a serious challenge to the predominance of drugs in treating depression. Nine out of 10 GPs say they’ve been forced to dish out drugs because they don’t have proper access to talking treatments such as cognitive behavioural therapy, which are recommended as the first-line treatment for mild to moderate depression.”
Anti Depressants A Waste Of Time

 
 
New research has shown that new generation anti-depressants work no better that placebo dummy pills seized upon evidence that doctors are over prescribing.

 
Campaigners from the Mental Health said that millions of people with depression are not getting sufficient access to talking to therapists due to GP’s being over reliant on prescribing drugs such as Prozac.  

 
It follows a review of clinical trials that found that such drugs had no more effect than a placebo for mildly depressed patients and for most people suffering severe depression.
The study showed that even trials suggesting benefits for severely depressed people did not provide evidence of clear clinical benefit, researchers said.
Dr Tim Kendall, deputy director of the Royal College of Psychiatrists Research Unit, said the findings were “fantastically important”.
A group of experts, led by Professor Irving Kirsch, from the Department of Psychology at the University of Hull, analysed 47 clinical trials using data released under Freedom of Information rules by the US Food and Drug Administration.
The researchers looked at four commonly used anti-depressants and the clinical trials submitted to gain licensing approval. They included anti-depressants regularly prescribed in the UK, including fluoxetine (Prozac), venlafaxine (Efexor) and paroxetine (Seroxat).
They found little evidence of benefit when analysing both unpublished and published data from the drug companies. Furthermore, the seemingly good results for very severely depressed patients came from the fact a patient’s response to the dummy pill decreased rather than any notable increase in their response to antidepressants.
Professor Kirsch said: “The difference in improvement between patients taking placebos and patients taking antidepressants is not very great. This means that depressed people can improve without chemical treatments.”
Alison Cobb, policy officer at mental health charity Mind, said: “This research is a serious challenge to the predominance of drugs in treating depression. Nine out of 10 GPs say they’ve been forced to dish out drugs because they don’t have proper access to talking treatments such as cognitive behavioural therapy, which are recommended as the first-line treatment for mild to moderate depression.”
Womens Clothing

Robert De Nero on terrorism

WWW.J-LOU.COM

Tens of thousands of people worldwide are planning to “panic-buy” carrots as part of a joke campaign on Facebook.

More than 91,000 Facebook users have signed up to a group called “On May 15, 2008, everybody needs to go out and panic buy carrots”.

They plan to go out at 2pm on the designated day and buy as many carrots as they can, reports Sky News.

Student Freya Valentine, who created the original site, insists it is all just a bit of fun.

“We know we’re not going to cause a massive world-wide shortage,” she said.

“To the carroty people who are saying this could never happen - maybe you should be thankful for the imminent rise we are probably going to make it your profits on May 15.”

David Martin, vice-chairman of the British Carrot Growers’ Association, is excited by the idea.

“It’s an extraordinary proposition,” he said.

“Purchasers can be assured they’ll have a fine product in the middle of May - as long as they buy British carrots. Bring it on! Let’s try and reach a million members!”

The 986 members plan to turn panic-bought carrots into soups and other carrot-related dishes, and deliver their produce to the needy and homeless.

Womens Knitwear